JP2022545947A5 - - Google Patents
Info
- Publication number
- JP2022545947A5 JP2022545947A5 JP2022513412A JP2022513412A JP2022545947A5 JP 2022545947 A5 JP2022545947 A5 JP 2022545947A5 JP 2022513412 A JP2022513412 A JP 2022513412A JP 2022513412 A JP2022513412 A JP 2022513412A JP 2022545947 A5 JP2022545947 A5 JP 2022545947A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1912437.9 | 2019-08-30 | ||
| GBGB1912437.9A GB201912437D0 (en) | 2019-08-30 | 2019-08-30 | CR2 Binding Proteins and their use in Medical Therapy |
| PCT/EP2020/074049 WO2021038023A1 (en) | 2019-08-30 | 2020-08-28 | Cr2 binding proteins and their use in medical therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545947A JP2022545947A (ja) | 2022-11-01 |
| JP2022545947A5 true JP2022545947A5 (enExample) | 2023-08-31 |
| JP7603061B2 JP7603061B2 (ja) | 2024-12-19 |
Family
ID=68207176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513412A Active JP7603061B2 (ja) | 2019-08-30 | 2020-08-28 | Ｃｒ２結合タンパク質および医学的治療におけるそれらの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230032643A1 (enExample) |
| EP (1) | EP4021938A1 (enExample) |
| JP (1) | JP7603061B2 (enExample) |
| KR (1) | KR20220053000A (enExample) |
| CN (1) | CN114375305A (enExample) |
| AR (1) | AR119865A1 (enExample) |
| AU (1) | AU2020338807A1 (enExample) |
| BR (1) | BR112022003623A2 (enExample) |
| CA (1) | CA3151687A1 (enExample) |
| GB (1) | GB201912437D0 (enExample) |
| IL (1) | IL290649A (enExample) |
| MX (1) | MX2022002478A (enExample) |
| TW (1) | TWI851801B (enExample) |
| WO (1) | WO2021038023A1 (enExample) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| EP1001021B1 (en) * | 1998-09-25 | 2003-08-27 | Wolfgang Prodinger | Monoclonal antibody to human CD21, and its uses |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| US20050089932A1 (en) | 2001-04-26 | 2005-04-28 | Avidia Research Institute | Novel proteins with targeted binding |
| US20050053973A1 (en) | 2001-04-26 | 2005-03-10 | Avidia Research Institute | Novel proteins with targeted binding |
| JP2004529945A (ja) * | 2001-05-17 | 2004-09-30 | ラ ホヤ ファーマシューティカル カンパニー | Ｃｄ２１を阻害する薬剤を使用して抗体媒介性病理を処置する方法 |
| AU2003298650B2 (en) * | 2002-11-15 | 2010-03-11 | Musc Foundation For Research Development | Complement receptor 2 targeted complement modulators |
| US20050164301A1 (en) | 2003-10-24 | 2005-07-28 | Avidia Research Institute | LDL receptor class A and EGF domain monomers and multimers |
| US8961967B2 (en) | 2009-11-30 | 2015-02-24 | Janssen Biotech, Inc. | Antibody Fc mutants with ablated effector functions |
| BR112012029067A2 (pt) * | 2010-05-14 | 2019-09-24 | Univ Colorado Regents | grupos-alvo de receptor do complemento 2 (cr2) melhorados. |
| WO2016187216A1 (en) * | 2015-05-18 | 2016-11-24 | Bluebird Bio, Inc. | Anti-ror1 chimeric antigen receptors |
| WO2017189281A1 (en) * | 2016-04-27 | 2017-11-02 | The Regents Of The University Of Michigan | C3d cellular and acellular vaccines for the prevention and treatment of cancer |
-
2019
- 2019-08-30 GB GBGB1912437.9A patent/GB201912437D0/en not_active Ceased
-
2020
- 2020-08-28 JP JP2022513412A patent/JP7603061B2/ja active Active
- 2020-08-28 US US17/639,096 patent/US20230032643A1/en active Pending
- 2020-08-28 EP EP20767985.3A patent/EP4021938A1/en active Pending
- 2020-08-28 CA CA3151687A patent/CA3151687A1/en active Pending
- 2020-08-28 WO PCT/EP2020/074049 patent/WO2021038023A1/en not_active Ceased
- 2020-08-28 BR BR112022003623A patent/BR112022003623A2/pt unknown
- 2020-08-28 CN CN202080060956.4A patent/CN114375305A/zh active Pending
- 2020-08-28 KR KR1020227010200A patent/KR20220053000A/ko active Pending
- 2020-08-28 TW TW109129646A patent/TWI851801B/zh active
- 2020-08-28 AU AU2020338807A patent/AU2020338807A1/en not_active Abandoned
- 2020-08-28 MX MX2022002478A patent/MX2022002478A/es unknown
- 2020-08-28 AR ARP200102433A patent/AR119865A1/es not_active Application Discontinuation
-
2022
- 2022-02-15 IL IL290649A patent/IL290649A/en unknown